AI · HK Tech — Fair value
A slow-moving intrinsic anchor per name — earnings power and discounted cash flow, residual income for banks — answering what to pay, never when to trade.
| Ticker | Name | Close | FV/sh | Method | MoS | Verdict | Quality | F | Bargain | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2318 | Aac Technologies Holdings | 54.00 | 104.79* | ResInc | — | n/a · currency | 17.0 | 6 | ||
| 1024 | KUAISHOU-W | 31.26 | 52.57 | EPV | +41% | UNDERVALUED | 7.0 | 5 | ||
| 9618 | JD-SW | 106.20 | 144.20 | EPV | +26% | UNDERVALUED | 3.0 | 7 | ||
| 0148 | KINGBOARD HLDG | 52.75 | 55.70 | EPV | +5% | UNDERVALUED | 11.0 | 6 | ||
| 2382 | Sunny Optical Technology | 69.10 | 67.39 | EPV | -3% | GROWTH PRICED IN | 6.0 | 7 | ||
| 1810 | XIAOMI CORP-W | 26.36 | 23.95 | EPV | -10% | GROWTH PRICED IN | 2.0 | 6 | ||
| 0700 | TENCENT | 428.40 | 313.41 | EPV | -37% | FAIR | 5.0 | 6 | ||
| 9988 | BABA-SW | 107.50 | 63.75 | EPV | -69% | GROWTH PRICED IN | 16.0 | 3 | ||
| 0992 H | Lenovo Group Limited | 31.30 | 18.51 | EPV | -69% | FAIR | 1.0 | 7 | ||
| 3750 | CATL | 547.50 | 302.85 | EPV | -81% | FAIR | 4.0 | 6 | ||
| 1211 | BYD | 79.85 | 39.45 | EPV | -102% | GROWTH PRICED IN | 18.0 | 5 | ||
| 0522 | ASMPT | 161.80 | 31.94 | EPV | -407% | GROWTH PRICED IN | 12.0 | 4 | ||
| 0981 | SMIC | 63.15 | 9.94 | EPV | -535% | GROWTH PRICED IN | 13.5 | 6 | ||
| 0772 | CHINA LIT | 19.68 | 2.72 | EPV | -622% | GROWTH PRICED IN | 19.0 | 3 | ||
| 6869 | YOFC | 183.50 | 13.10 | EPV | -1301% | GROWTH PRICED IN | 13.5 | 6 | ||
| 1347 | Hua Hong Semiconductor | 111.70 | 5.86 | EPV | -1805% | GROWTH PRICED IN | 15.0 | 5 | ||
| 0100 | MINIMAX-W | 270.00 | -370.63* | EPV | — | n/a · no data | 8.0 | 5 | ||
| 0068 | MANYCORE TECH | 9.10 | -1.97* | EPV | — | n/a · no data | 9.0 | 6 | ||
| 2513 | KNOWLEDGE ATLAS | 793.00 | -94.86* | EPV | — | n/a · no data | 10.0 | 3 | ||
| 7709 | XL2CSOPHYNIX | 44.10 | — | NA_ETF | — | n/a · ETF | 20.5 | 0 | ||
| 7747 | XL2CSOPSMSN | 76.30 | — | NA_ETF | — | n/a · ETF | 20.5 | 0 |
How to read this table
- Ticker · H
- The exchange symbol; an H pill marks a name this book currently holds.
- Close
- The latest settled market price — what the stock costs today.
- FV/sh (fair value per share)
- Our estimate of what one share is intrinsically worth, from the company's own earnings power and cash flow — a slow-moving anchor refreshed with quarterly results, deliberately independent of the day's price action.
- Method
- How that fair value was computed: EPV (earnings power value — what steady current earnings are worth, assuming no growth), DCF (discounted cash flow — future cash flows brought back to today's dollars), or Bank (residual income — the right framework for banks, whose "cash flow" is not comparable to an industrial's).
- MoS (margin of safety)
- How far the price sits below fair value, as a percentage — the discount you get for buying today. Positive (teal) = priced below fair value; negative (red) = priced above it. The bar makes the size of the gap scannable.
- Verdict
- UNDERVALUED — price below the fair-value anchor. FAIR — above the anchor but still below the growth-inclusive DCF value. GROWTH PRICED IN — the price already assumes the optimistic growth case plays out. OVERVALUED VS RI — a bank trading above its residual-income value. When no verdict applies, the pill says why: n/a · currency — the listing trades in a different currency than the company reports in (typically an ADR: the price is USD per depositary share, the statements aren't), so price and fair value can't honestly be compared and the MoS is withheld (the FV/sh shown* is in the reporting currency); n/a · ETF — a fund holds other assets, so company-earnings frameworks don't apply; n/a · no data — not enough fundamentals to compute a fair value. n/a rows carry no valuation force downstream.
- Quality
- The name's rank within this book on a composite of five quality measures: return on invested capital, gross profitability, free-cash-flow yield, revenue growth, and the F-Score. Earlier letters = higher quality.
- F (Piotroski F-Score)
- A 0–9 checklist of accounting health — profitability, improving balance sheet, operating efficiency. 7–9 is strong; below 4 is a warning.
How valuation is used
Valuation re-ranks and resizes technical buy candidates by a bounded amount and can amplify a signal-based sell — it never originates a trade on its own. A richly priced name that is trending is not a sell case; a cheap one with no signal is not a buy case. n/a rows (ETFs, currency mismatches) carry no valuation force.